Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1

Journal of Clinical Lipidology

Volumn 8, Issue 6, 2014, Pages 635-639

  Ahmad, Zahid ^a   Wilson, Don P ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b Children's Medical Center   (United States)

Author keywords

Eruptive xanthomas; Familial chylomicronemia syndrome; GPIHBP1; Hypertriglyceridemia; Lipemia; Lipoprotein lipase (LPL); Medium chain triglycerides; Triglycerides; Type 1 hyperlipoproteinemia

Indexed keywords

INFUSION FLUID; MEDIUM CHAIN TRIACYLGLYCEROL; TRIACYLGLYCEROL; GPIHBP1 PROTEIN, HUMAN; LIPOPROTEIN RECEPTOR;

ACUTE PANCREATITIS; ARTICLE; ARTIFICIAL MILK; CASE REPORT; DIET THERAPY; FAMILIAL CHYLOMICRONEMIA SYNDROME; FAMILIAL DISEASE; FEMALE; GENE; GENE MUTATION; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED HIGH DENSITY LIPOPROTEINBINDING PROTEIN 1 GENE; HOSPITAL DISCHARGE; HUMAN; HYPERTRIGLYCERIDEMIA; INFANT; LINSEED; MEDICAL HISTORY; NONSENSE MUTATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; ACUTE DISEASE; ADMINISTRATION AND DOSAGE; ANAMNESIS; COMPLICATION; DISEASE FREE SURVIVAL; FEEDING BEHAVIOR; GENETICS; HYPERLIPOPROTEINEMIA TYPE 1; MUTATION; NUCLEOTIDE SEQUENCE; PANCREATITIS;

ACUTE DISEASE; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; FEMALE; FOOD HABITS; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; INFANT; INFANT FORMULA; MEDICAL HISTORY TAKING; MUTATION; PANCREATITIS; RECEPTORS, LIPOPROTEIN; TRIGLYCERIDES;

EID: 84928828530     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2014.08.010     Document Type: Article

References (31)

1. J.D. Brunzell Clinical practice. Hypertriglyceridemia N Engl J Med 357 2007 1009 1017
2. M.R. Fortson, S.N. Freedman, and P.D. Webster 3rd Clinical assessment of hyperlipidemic pancreatitis Am J Gastroenterol 90 1995 2134 2139
3. P.A. Banks, and M.L. Freeman Practice guidelines in acute pancreatitis Am J Gastroenterol 101 2006 2379 2400
4. B. Gloor, C.A. Muller, M. Worni, M.E. Martignoni, W. Uhl, and M.W. Buchler Late mortality in patients with severe acute pancreatitis Br J Surg 88 2001 975 979
5. S.L. Werlin, S. Kugathasan, and B.C. Frautschy Pancreatitis in children J Pediatr Gastroenterol Nutr 37 2003 591 595
6. J.R. DeBanto, P.S. Goday, M.R. Pedroso, and et al. Acute pancreatitis in children Am J Gastroenterol 97 2002 1726 1731
7. S.S. Deep, and J.D. Brunzell Chapter 117: Familial Lipoprotein Lipase Deficiency, Apo C-II Deficiency, and Hepatic Lipase Deficiency. Metabolic and Molecular Bases of Inherited Disease 2006 The McGraw-Hill Companies
8. C. Priore Oliva, F. Carubbi, F.G. Schaap, S. Bertolini, and S. Calandra Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene J Intern Med 263 2008 450 458
9. C. Marcais, B. Verges, S. Charriere, and et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment J Clin Invest 115 2005 2862 2869
10. M. Peterfy, O. Ben-Zeev, H.Z. Mao, and et al. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia Nat Genet 39 2007 1483 1487
11. A.P. Beigneux, R. Franssen, A. Bensadoun, and et al. Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein Lipase Arterioscler Thromb Vasc Biol 29 2009 956 962
12. O. Adeyo, C.N. Goulbourne, A. Bensadoun, A.P. Beigneux, L.G. Fong, and S.G. Young Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins J Intern Med 272 2012 528 540
13. B.S. Davies, A.P. Beigneux, R.H. Barnes 2nd, and et al. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries Cell Metab 12 2010 42 52
14. A.P. Beigneux, B.S. Davies, P. Gin, and et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons Cell metabolism 5 2007 279 291
15. J.J. Rios, S. Shastry, J. Jasso, and et al. Deletion of GPIHBP1 causing severe chylomicronemia J Inherit Metab Dis 35 2012 531 540
16. N. Chokshi, S.D. Blumenschein, Z. Ahmad, and A. Garg Genotype-phenotype relationships in patients with type I hyperlipoproteinemia J Clin Lipidol 8 2014 287 295
17. A.C. Bach, and V.K. Babayan Medium-chain triglycerides: an update Am J Clin Nutr 36 1982 950 962
18. T.B. Seaton, S.L. Welle, M.K. Warenko, and R.G. Campbell Thermic effect of medium-chain and long-chain triglycerides in man Am J Clin Nutr 44 1986 630 634
19. E.A. Mascioli, S. Randall, K.A. Porter, and et al. Thermogenesis from intravenous medium-chain triglycerides JPEN J Parenter Enteral Nutr 15 1991 27 31
20. E.A. Mascioli, S. Lopes, S. Randall, and et al. Serum fatty acid profiles after intravenous medium chain triglyceride administration Lipids 24 1989 793 798
21. A. Garg Clinical review#: Lipodystrophies: genetic and acquired body fat disorders J Clin Endocrinol Metab 96 2011 3313 3325
22. E.W. Clayton Ethical, legal, and social implications of genomic medicine N Engl J Med 349 2003 562 569
23. B.W. Ramsey, J. Davies, N.G. McElvaney, and et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation N Engl J Med 365 2011 1663 1672
24. D. Gaudet, J. Methot, S. Dery, and et al. Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial Gene Ther 20 2013 361 369
25. E.S. Stroes, M.C. Nierman, J.J. Meulenberg, and et al. Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients Arterioscler Thromb Vasc Biol 28 2008 2303 2304
26. J.C. Feoli-Fonseca, E. Levy, M. Godard, and M. Lambert Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study J Pediatr 133 1998 417 423
27. Harold Bays Fish Oils in the Treatment of Dyslipidemia and Cardiovascular Disease P.O. Kwitervovich, Johns Hopkins Textbook of Dyslipidemia 2010 Lippincott, Williams and Wilkins Philadelphia, PA
28. M.A. Jabbar, M.I. Zuhri-Yafi, and J. Larrea Insulin therapy for a non-diabetic patient with severe hypertriglyceridemia J Am Coll Nutr 17 1998 458 461
29. J.C. Sleth, E. Lafforgue, R. Servais, and et al. A case of hypertriglycideremia-induced pancreatitis in pregnancy: value of heparin Annales francaises d'anesthesie et de reanimation 23 2004 835 837
30. A.S. Wierzbicki, T.M. Reynolds, and M.A. Crook Usefulness of Orlistat in the treatment of severe hypertriglyceridemia Am J Cardiol 89 2002 229 231
31. P. Blackett, J. Tryggestad, S. Krishnan, and et al. Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat J Clin Lipidol 7 2013 132 139